European Antimicrobial Resistance Surveillance Network

European Antimicrobial Resistance Surveillance Network
Name	European Antimicrobial Resistance Surveillance Network
Abbreviation	EARS-Net
Formation	1999
Type	Public health network
Headquarters	Stockholm
Region served	Europe
Parent organization	European Centre for Disease Prevention and Control

European Antimicrobial Resistance Surveillance Network

The European Antimicrobial Resistance Surveillance Network coordinates antimicrobial resistance monitoring across European Union member states, the European Economic Area, and collaborating countries, providing standardized data for policymakers and clinicians. It delivers annual reports and interactive datasets used by institutions such as the European Centre for Disease Prevention and Control, the World Health Organization, and national public health institutes including Public Health England, Robert Koch Institute, and Instituto de Salud Carlos III. The network informs strategies tied to initiatives like the One Health agenda, the European Green Deal, and the United Nations antimicrobial resistance Global Action Plan.

Overview

EARS-Net aggregates laboratory susceptibility data from sentinel laboratories and national reference centres across Germany, France, Italy, Spain, Sweden, Norway, Denmark, Poland, Greece, Portugal, Netherlands, Belgium, Austria, Switzerland, Ireland, Finland, Czech Republic, Hungary, Romania, Bulgaria, Slovakia, Slovenia, Croatia, Lithuania, Latvia, Estonia, Luxembourg, Iceland, Liechtenstein, Malta', and candidate countries. The dataset focuses on key pathogens including Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, Pseudomonas aeruginosa, Enterococcus faecalis, Enterococcus faecium, and Streptococcus pneumoniae, linking resistance trends to clinical guidelines from bodies like the European Medicines Agency and the European Society of Clinical Microbiology and Infectious Diseases.

History and Development

EARS-Net was initiated in response to rising multidrug resistance highlighted by surveillance programmes in the United Kingdom, Netherlands, and Sweden during the 1990s, and formalized under the auspices of the European Centre for Disease Prevention and Control after its establishment. Early collaborations drew on experience from projects such as the Surveillance Networks coordinated by the World Health Organization Regional Office for Europe and national initiatives like the DANMAP programme in Denmark and the SENTRY Antimicrobial Surveillance Program. Milestones include integration with the European Antimicrobial Resistance Collaborating Network, harmonization of breakpoints via the European Committee on Antimicrobial Susceptibility Testing, and adoption of reporting standards aligned with the Global Antimicrobial Resistance Surveillance System.

Governance and Structure

Governance combines technical advisory groups, national focal points, and laboratory networks linked to agencies such as the European Commission, the Secretariat of the United Nations, and national ministries of health in capitals such as Stockholm, Brussels, Berlin, Paris, and Rome. Steering committees include experts from institutions like the Institut Pasteur, the London School of Hygiene & Tropical Medicine, the Karolinska Institutet, and the National Institute for Public Health and the Environment; operational management resides within the European Centre for Disease Prevention and Control in Stockholm. Legal frameworks intersect with directives produced by the Council of the European Union and policies influenced by the European Parliament.

Surveillance Methods and Data Collection

Methods rely on passive laboratory-based reporting, standardized antimicrobial susceptibility testing interpreted by criteria from the European Committee on Antimicrobial Susceptibility Testing and complemented by quality assurance from reference laboratories such as the European Reference Laboratory Network. Data pipelines use coding and information systems interoperable with platforms like the European Surveillance System and national laboratory information systems from agencies such as the Robert Koch Institute and Santé publique France. Sampling focuses on blood and cerebrospinal fluid isolates, employing molecular typing methods exemplified by collaborations with institutions like Wellcome Sanger Institute, Max Planck Institute for Infection Biology, and the Institut Pasteur for genomic surveillance and outbreak investigation.

Findings and Impact

Reports document long-term increases and regional variation in resistance phenotypes, including extended-spectrum beta-lactamase producers in Escherichia coli and carbapenem-resistant Klebsiella pneumoniae, trends that have shaped treatment guidelines from organizations like the European Society of Clinical Microbiology and Infectious Diseases and influenced procurement decisions at hospitals such as Charité – Universitätsmedizin Berlin, Rigshospitalet, and Hospital Clínic de Barcelona. EARS-Net data underpinned policy instruments like the EU Action Plan on Antimicrobial Resistance and informed global assessments by the World Health Organization and research outputs from universities including University of Oxford, University of Cambridge, Imperial College London, Uppsala University, and University of Copenhagen.

Collaborations and Partnerships

EARS-Net partners with multilateral and national entities including the World Health Organization, the Food and Agriculture Organization, the Organisation for Economic Co-operation and Development, and bilateral collaborations with institutions such as the Centers for Disease Control and Prevention and the National Institutes of Health. Academic partnerships include the London School of Hygiene & Tropical Medicine, University of Edinburgh, KU Leuven, Ghent University, University of Helsinki, Trinity College Dublin, University of Milan, Sapienza University of Rome, and research consortia like the European Research Area. Industry engagement occurs through dialogue with corporations and associations such as the European Federation of Pharmaceutical Industries and Associations.

Challenges and Future Directions

Challenges include harmonizing laboratory methods across diverse healthcare systems in countries like Romania, Bulgaria, and Hungary; expanding genomic surveillance with capacity building in regions represented by institutions such as Vilnius University and Riga Stradiņš University; and integrating One Health data spanning human, veterinary, and environmental sectors exemplified by partnerships with the Veterinary Medicines Directorate and agricultural research centres. Future directions emphasize strengthening interoperability with the European Health Data Space, leveraging genomic epidemiology from centres like the Wellcome Sanger Institute and EMBL, and informing policy within frameworks such as the European Commission Green Paper initiatives and the United Nations sustainable development agenda.

Category:Public health surveillance Category:Antimicrobial resistance